Browse by Journal Title

Article

LncRNA MIR31HG fosters stemness malignant features of non-small cell lung cancer via H3K4me1- and H3K27Ace-mediated GLI2 expression.
Chen, W. and Wang, F. and Yu, X. and Qi, J. and Dong, H. and Cui, B. and Zhang, Q. and Wu, Y. and An, J. and Ni, N. and Liu, C. and Han, Y. and Zhang, S. and Schmitt, C.A. and Deng, J. and Yu, Y. and Du, J.
Oncogene 10 November 2023 (In Press)

Combinatorial treatment with statins and niclosamide prevents CRC dissemination by unhinging the MACC1-β-catenin-S100A4 axis of metastasis.
Kortüm, B. and Radhakrishnan, H. and Zincke, F. and Sachse, C. and Burock, S. and Keilholz, U. and Dahlmann, M. and Walther, W. and Dittmar, G. and Kobelt, D. and Stein, U.
Oncogene 41 (39): 4446-4458. 23 September 2022

Single-cell RNA sequencing reveals distinct tumor microenvironmental patterns in lung adenocarcinoma.
Bischoff, P. and Trinks, A. and Obermayer, B. and Pett, J.P. and Wiederspahn, J. and Uhlitz, F. and Liang, X. and Lehmann, A. and Jurmeister, P. and Elsner, A. and Dziodzio, T. and Rückert, J.C. and Neudecker, J. and Falk, C. and Beule, D. and Sers, C. and Morkel, M. and Horst, D. and Blüthgen, N. and Klauschen, F.
Oncogene 40 : 6748–6758. 16 December 2021

The newly identified MEK1 tyrosine phosphorylation target MACC1 is druggable by approved MEK1 inhibitors to restrict colorectal cancer metastasis.
Kobelt, D. and Perez-Hernandez, D. and Fleuter, C. and Dahlmann, M. and Zincke, F. and Smith, J. and Migotti, R. and Popp, O. and Burock, S. and Walther, W. and Dittmar, G. and Mertins, P. and Stein, U.
Oncogene 40 (34): 5286-5301. 26 August 2021

Non-canonical HIF-1 stabilization contributes to intestinal tumorigenesis.
Rohwer, N. and Jumpertz, S. and Erdem, M. and Egners, A. and Warzecha, K.T. and Fragoulis, At. and Kühl, A.A. and Kramann, R. and Neuss, S. and Rudolph, I. and Endermann, T. and Zasada, C. and Apostolova, I. and Gerling, M. and Kempa, S. and Hughes, R. and Lewis, C.E. and Brenner, W. and Malinowski, M.B. and Stockmann, M. and Schomburg, L. and Faller, W. and Sansom, O.J. and Tacke, F. and Morkel, M. and Cramer, T.
Oncogene 38 (28): 5670-5685. 11 July 2019

Human SLFN5 is a transcriptional co-repressor of STAT1-mediated interferon responses and promotes the malignant phenotype in glioblastoma.
Arslan, A.D. and Sassano, A. and Saleiro, D. and Lisowski, P. and Kosciuczuk, E.M. and Fischietti, M. and Eckerdt, F. and Fish, E.N. and Platanias, L.C.
Oncogene 36 (43): 6006-6019. 26 October 2017

TMEM43/LUMA is a key signaling component mediating EGFR-induced NF-κB activation and tumor progression.
Jiang, C. and Zhu, Y. and Zhou, Z. and Gumin, J. and Bengtsson, L. and Wu, W. and Songyang, Z. and Lang, F.F. and Lin, X.
Oncogene 36 (20): 2813-2823. 18 May 2017

SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival.
Schmid, F. and Wang, Q. and Huska, M.R. and Andrade-Navarro, M.A. and Lemm, M. and Fichtner, I. and Dahlmann, M. and Kobelt, D. and Walther, W. and Smith, J. and Schlag, P.M. and Stein, U.
Oncogene 35 (46): 5942-5952. 17 November 2016

Comprehensive translational control of tyrosine kinase expression by upstream open reading frames.
Wethmar, K. and Schulz, J. and Muro, E.M. and Talyan, S. and Andrade-Navarro, M.A. and Leutz, A.
Oncogene 35 (13): 1736-1742. 31 March 2016

A link between inflammation and metastasis: serum amyloid A1 and A3 induce metastasis, and are targets of metastasis-inducing S100A4.
Hansen, M.T. and Forst, B. and Cremers, N. and Quagliata, L. and Ambartsumian, N. and Grum-Schwensen, B. and Klingelhoefer, J. and Abdul-Al, A. and Herrmann, P. and Osterland, M. and Stein, U. and Nielsen, G.H. and Scherer, P.E. and Lukanidin, E. and Sleeman, J.P. and Grigorian, M.
Oncogene 34 (4): 424-435. 22 January 2015

The immediate early gene Ier2 promotes tumor cell motility and metastasis, and predicts poor survival of colorectal cancer patients.
Neeb, A. and Wallbaum, S. and Novac, N. and Dukovic-Schulze, S. and Scholl, I. and Schreiber, C. and Schlag, P. and Moll, J. and Stein, U. and Sleeman, J.P.
Oncogene 31 (33): 3796-3806. August 2012

Serum/glucocorticoid-regulated kinase 1 (SGK1) is a prominent target gene of the transcriptional response to cytokines in multiple myeloma and supports the growth of myeloma cells.
Fagerli, U.M. and Ullrich, K. and Stuehmer, T. and Holien, T. and Koechert, K. and Holt, R.U. and Bruland, O. and Chatterjee, M. and Nogai, H. and Lenz, G. and Shaughnessy, J.D. and Mathas, S. and Sundan, A. and Bargou, R.C. and Doerken, B. and Borset, M. and Janz, M.
Oncogene 30 (28): 3198-3206. 14 July 2011

High-level expression of Mastermind-like 2 contributes to aberrant activation of the NOTCH signaling pathway in human lymphomas.
Koechert, K. and Ullrich, K. and Kreher, S. and Aster, J.C. and Kitagawa, M. and Joehrens, K. and Anagnostopoulos, I. and Jundt, F. and Lamprecht, B. and Zimber-Strobl, U. and Stein, H. and Janz, M. and Doerken, B. and Mathas, S.
Oncogene 30 (15): 1831-1840. 14 April 2011

The immune response to sporadic colorectal cancer in a novel mouse model.
Czeh, M. and Loddenkemper, C. and Shalapour, S. and Schoen, C. and Robine, S. and Goldscheid, E. and Stein, H. and Schueler, T. and Willimsky, G. and Blankenstein, T.
Oncogene 29 (50): 6591-6602. 16 December 2010

ASAP1 promotes tumor cell motility and invasiveness, stimulates metastasis formation in vivo, and correlates with poor survival in colorectal cancer patients.
Mueller, T. and Stein, U. and Poletti, A. and Garzia, L. and Rothley, M. and Plaumann, D. and Thiele, W. and Bauer, M. and Galasso, A. and Schlag, P. and Pankratz, M. and Zollo, M. and Sleeman, J.P.
Oncogene 29 (16): 2393-2403. 22 April 2010

Cooperative effect of p21Cip1/WAF-1 and 14-3-3sigma on cell cycle arrest and apoptosis induction by p14ARF.
Hemmati, P.G. and Normand, G. and Gillissen, B. and Wendt, J. and Doerken, B. and Daniel, P.T.
Oncogene 27 (53): 6707-6719. 4 December 2008

Common tumour p53 mutations in immortalized cells from Hupki mice heterozygous at codon 72.
Reinbold, M. and Luo, J.L. and Nedelko, T. and Jerchow, B. and Murphy, M.E. and Whibley, C. and Wei, Q. and Hollstein, M.
Oncogene 27 (19): 2788-2794. 24 April 2008

Frequent loss of expression of the pro-apoptotic protein Bim in renal cell carcinoma: evidence for contribution to apoptosis resistance.
Zantl, N. and Weirich, G. and Zall, H. and Seiffert, B.M. and Fischer, S.F. and Kirschnek, S. and Hartmann, C. and Fritsch, R.M. and Gillissen, B. and Daniel, P.T. and Haecker, G.
Oncogene 26 (49): 7038-7048. 25 October 2007

Enhanced tumorigenicity of fibroblasts transformed with human herpesvirus 8 chemokine receptor vGPCR by successive passage in nude and immunocompetent mice.
Thirunarayanan, N. and Cifire, F. and Fichtner, I. and Posner, S. and Benga, J. and Reiterer, P. and Kremmer, E. and Koelble, K. and Lipp, M.
Oncogene 26 (39): 5702-5712. 23 August 2007

Bak functionally complements for loss of Bax during p14(ARF)-induced mitochondrial apoptosis in human cancer cells.
Hemmati, P.G. and Guener, D. and Gillissen, B. and Wendt, J. and von Haefen, C. and Chinnadurai, G. and Doerken, B. and Daniel, P.T.
Oncogene 25 (50): 6582-6594. 26 October 2006

Combined treatment of colorectal tumours with agonistic TRAIL receptor antibodies HGS-ETR1 and HGS-ETR2 and radiotherapy: enhanced effects in vitro and dose-dependent growth delay in vivo.
Marini, P. and Denzinger, S. and Schiller, D. and Kauder, S. and Welz, S. and Humphreys, R. and Daniel, P.T. and Jendrossek, V. and Budach, W. and Belka, C.
Oncogene 25 : 5145-5154. 24 August 2006

Apoptin-induced cell death is modulated by Bcl-2 family members and is Apaf-1 dependent.
Burek, M. and Maddika, S. and Burek, C.J. and Daniel, P.T. and Schulze-Osthoff, K. and Los, M.
Oncogene 25 : 2213-2222. 6 April 2006

A novel Bcl-x splice product, Bcl-xAK, triggers apoptosis in human melanoma cells without BH3 domain.
Hossini, A.M. and Geilen, C.C. and Fecker, L.F. and Daniel, P.T. and Eberle, J.
Oncogene 25 : 2160-2169. 6 April 2006

ELA2 is regulated by hematopoietic transcription factors, but not repressed by AML1-ETO.
Lausen, J. and Liu, S. and Fliegauf, M. and Luebbert, M. and Werner, M.H.
Oncogene 25 (9): 1349-1357. 2 March 2006

Induction of p21CIP/WAF-1 and G2 arrest by ionizing irradiation impedes caspase-3-mediated apoptosis in human carcinoma cells.
Wendt, J. and Radetzki, S. and von Haefen, C. and Hemmati, P.G. and Guener, D. and Schulze-Osthoff, K. and Doerken, B. and Daniel, P.T.
Oncogene 25 : 972-980. 16 February 2006

Equivalent effect of DNA damage-induced apoptotic cell death or long-term cell cycle arrest on colon carcinoma cell proliferation and tumour growth.
Bhonde, M.R. and Hanski, M.L. and Notter, M. and Gillissen, B.F. and Daniel, P.T. and Zeitz, M. and Hanski, C.
Oncogene 25 : 165-175. 12 January 2006

Arsenic trioxide induces regulated, death receptor-independent cell death through a Bcl-2-controlled pathway.
Scholz, C. and Richter, A. and Lehmann, M. and Schulze-Osthoff, K. and Doerken, B. and Daniel, P.T.
Oncogene 24 (47): 7031-7042. 27 October 2005

HNF4alpha reduces proliferation of kidney cells and affects genes deregulated in renal cell carcinoma.
Lucas, B. and Grigo, K. and Erdmann, S. and Lausen, J. and Klein-Hitpass, L. and Ryffel, G.U.
Oncogene 24 (42): 6418-6431. 22 September 2005

Prediction of doxorubicin sensitivity in breast tumors based on gene expression profiles of drug-resistant cell lines correlates with patient survival.
Gyoerffy, B. and Serra, V. and Juerchott, K. and Abdul-Ghani, R. and Garber, M. and Stein, U. and Petersen, I. and Lage, H. and Dietel, M. and Schaefer, R.
Oncogene 24 (15): 7542-7551. 25 July 2005

Caspase-independent induction of apoptosis in human melanoma cells by the proapoptotic Bcl-2-related protein Nbk/Bik.
Oppermann, M. and Geilen, C.C. and Fecker, L.F. and Gillissen, B. and Daniel, P.T. and Eberle, J.
Oncogene 24 : 7369-7380. 4 July 2005

The broad-range cyclin-dependent kinase inhibitor UCN-01 induces apoptosis in colon carcinoma cells through transcriptional suppression of the Bcl-xL protein.
Bhonde, M.R. and Hanski, M.L. and Magrini, R. and Moorthy, D. and Mueller, A. and Sausville, E.A. and Kohno, K. and Wiegand, P. and Daniel, P.T. and Zeitz, M. and Hanski, C.
Oncogene 24 : 148-156. 6 January 2005

Type I and type II reactions in TRAIL-induced apoptosis - results from dose-response studies.
Rudner, J. and Jendrossek, V. and Lauber, K. and Daniel, P.T. and Wesselborg, S. and Belka, C.
Oncogene 24 : 130-140. 6 January 2005

Recurrent chromosomal aberrations in INK4a/ARF defective primary lymphomas predict drug responses in vivo.
Helmrich, A. and Lee, S. and O'Brien, P. and Doerken, B. and Lowe, S.W. and Schroeck, E. and Schmitt, C.A.
Oncogene 24 : 4174-4182. 1 January 2005

Loss of p21 disrupts p14ARF-induced G1 cell cycle arrest but augments p14ARF-induced apoptosis in human carcinoma cells.
Hemmati, P.G. and Normand, G. and Verdoodt, B. and von Haefen, C. and Hasenjaeger, A. and Guener, D. and Wendt, J. and Doerken, B. and Daniel, P.T.
Oncogene 24 (25): 4114-4128. 1 January 2005

Arsenic trioxide triggers a regulated form of caspase-independent necrotic cell death via the mitochondrial death pathway.
Scholz, C. and Wieder, T. and Staerck, L. and Essmann, F. and Schulze-Osthoff, K. and Doerken, B. and Daniel, P.T.
Oncogene 24 : 1904-1913. 1 January 2005

A network of clinically and functionally relevant genes is involved in the reversion of the tumorigenic phenotype of MDA-MB-231 breast cancer cells after transfer of human chromosome 8.
Seitz, S. and Frege, R. and Jacobsen, A. and Weimer, J. and Arnold, W. and Haefen, C.v. and Niederacher, D. and Schmutzler, R. and Arnold, N. and Scherneck, S.
Oncogene 24 (5): 869-879. 1 January 2005

YB-1 facilitates basal and 5-fluorouracil-inducible expression of the human major vault protein (MVP) gene.
Stein, U. and Bergmann, S. and Scheffer, G.L. and Scheper, R.J. and Royer, H.D. and Schlag, P.M. and Walther, W.
Oncogene 24 (22): 3606-3618. 1 January 2005

TRAIL sensitizes for ionizing irradiation-induced apoptosis through an entirely Bax-dependent mitochondrial cell death pathway.
Wendt, J. and von Haefen, C. and Hemmati, P. and Belka, C. and Doerken, B. and Daniel, P.T.
Oncogene 24 (25): 4052-4064. 1 January 2005

PARP-10, a novel Myc-interacting protein with poly(ADP-ribose) polymerase activity, inhibits transformation.
Yu, M. and Schreek, S. and Cerni, C. and Schamberger, C. and Lesniewicz, K. and Poreba, E. and Vervoorts, J. and Walsemann, G. and Groetzinger, J. and Kremmer, E. and Mehraein, Y. and Mertsching, J. and Kraft, R. and Austen, M. and Luscher-Firzlaff, J. and Luescher, B.
Oncogene 24 (12): 1982-1993. 1 January 2005

ST18 is a breast cancer tumor suppressor gene at human chromosome 8q11.2.
Jandrig, B. and Seitz, S. and Hinzmann, B. and Arnold, W. and Micheel, B. and Koelble, K. and Siebert, R. and Schwartz, A. and Ruecker, K. and Schlag, P.M. and Scherneck, S. and Rosenthal, A.
Oncogene 23 (57): 9295-9302. 18 October 2004

Multidomain Bcl-2 homolog Bax but not Bak mediates synergistic induction of apoptosis by TRAIL and 5-FU through the mitochondrial apoptosis pathway.
von Haefen, C. and Gillissen, B. and Hemmati, P.G. and Wendt, J. and Guener, D. and Mrozek, A. and Belka, C. and Doerken, B. and Daniel, P.T.
Oncogene 23 (50): 8320-8332. 27 September 2004

Tumor necrosis factor α sensitizes malignant cells to chemotherapeutic drugs via the mitochondrial apoptosis pathway independently of caspase-8 and NF-κB.
Schmelz, K. and Wieder, T. and Tamm, I. and Mueller, A. and Essmann, F. and Geilen, C.C. and Schulze-Osthoff, K. and Doerken, B. and Daniel, P.T.
Oncogene 23 (40): 6743-6759. 2 September 2004

Requirement of Hsp90 activity for IkappaB kinase (IKK) biosynthesis and for constitutive and inducible IKK and NF-kappaB activation.
Broemer, M. and Krappmann, D. and Scheidereit, C.
Oncogene 23 (31): 5378-5386. 8 July 2004

Smac induces cytochrome c release and apoptosis independently from Bax/Bcl-xL in a strictly caspase-3-dependent manner in human carcinoma cells.
Hasenjaeger, A. and Gillissen, B. and Mueller, A. and Normand, G. and Hemmati, P.G. and Schuler, M. and Doerken, B. and Daniel, P.T.
Oncogene 23 (26): 4523-4535. 3 June 2004

Adenine deoxynucleotides fludarabine and cladribine induce apoptosis in a CD95/Fas receptor, FADD and caspase-8-independent manner by activation of the mitochondrial cell death pathway.
Kloepfer, A. and Hasenjaeger, A. and Belka, C. and Schulze-Osthoff, K. and Doerken, B. and Daniel, P.T.
Oncogene 23 : 9408-9418. 1 January 2004

CD95/Fas signaling in human melanoma cells: conditional expression of CD95L/FasL overcomes the intrinsic apoptosis resistance of malignant melanoma and inhibits growth and progression of human melanoma xenotransplants.
Eberle, J. and Fecker, L.F. and Hossini, A.M. and Wieder, T. and Daniel, P.T. and Orfanos, C.E. and Geilen, C.C.
Oncogene 22 (57): 9131-9141. 11 December 2003

Induction of apoptosis by enediyne antibiotic calicheamicin gammaII proceeds through a caspase-mediated mitochondrial amplification loop in an entirely Bax-dependent manner.
Prokop, A. and Wrasidlo, W. and Lode, H. and Herold, R. and Lang, F. and Henze, G. and Doerken, B. and Wieder, T. and Daniel, P.T.
Oncogene 22 (57): 9107-9120. 11 December 2003

Induction of G0/G1 cell cycle arrest in ovarian carcinoma cells by the anti-inflammatory drug NS-398, but not by COX-2-specific RNA interference.
Denkert, C. and Fuerstenberg, A. and Daniel, P.T. and Koch, I. and Koebel, M. and Weichert, W. and Siegert, A. and Hauptmann, S.
Oncogene 22 (54): 8653-8661. 27 November 2003

SASH1: a candidate tumor suppressor gene on chromosome 6q24.3 is downregulated in breast cancer.
Zeller, C. and Hinzmann, B. and Seitz, S. and Prokoph, H. and Burkhard-Goettges, E. and Fischer, J. and Jandrig, B. and Schwarz, L.E. and Rosenthal, A. and Scherneck, S.
Oncogene 22 (19): 2972-2983. 15 May 2003

Pathogenesis of DNA repair-deficient cancers: a statistical meta-analysis of putative Real Common Target genes.
Woerner, S.M. and Benner, A. and Sutter, C. and Schiller, M. and Yuan, Y.P. and Keller, G. and Bork, P. and Doeberitz, M.V. and Gebert, J.F.
Oncogene 22 (15): 2226-2235. 17 April 2003

GATA-1 and c-myb crosstalk during red blood cell differentiation through GATA-1 binding sites in the c-myb promoter.
Bartunek, P. and Kralova, J. and Blendinger, G. and Dvorak, M. and Zenke, M.
Oncogene 22 (13): 1927-1935. 3 April 2003

Paclitaxel-induced apoptosis in BJAB cells proceeds via a death receptor-independent, caspases-3/-8-driven mitochondrial amplification loop.
von Haefen, C. and Wieder, T. and Essmann, F. and Schulze-Osthoff, K. and Doerken, B. and Daniel, P.T.
Oncogene 22 (15): 2236-2247. 1 April 2003

Overexpression of NPM-ALK induces different types of malignant lymphomas in IL-9 transgenic mice.
Lange, K. and Uckert, W. and Blankenstein, T. and Nadrowitz, R. and Bittner, C. and Renauld, J.C. and van Snick, J. and Feller, A.C. and Merz, H.
Oncogene 22 (4): 517-527. 30 January 2003

Distinct changes in gene expression induced by A-Myb, B-Myb and c-Myb proteins.
Rushton, J.J. and Davis, L.M. and Lei, W.L. and Mo, X.M. and Leutz, A. and Ness, S.A.
Oncogene 22 (2): 308-313. 16 January 2003

Ceramide induces mitochondrial activation and apoptosis via a Bax-dependent pathway in human carcinoma cells.
von Haefen, C. and Wieder, T. and Gillissen, B. and Staerck, L. and Graupner, V. and Doerken, B. and Daniel, P.T.
Oncogene 21 (25): 4009-4019. 6 June 2002

Adenovirus-mediated overexpression of p14ARF induces p53 and Bax-independent apoptosis.
Hemmati, P.G. and Gillissen, B. and von Haefen, C. and Wendt, J. and Staerck, L. and Guener, D. and Doerken, B. and Daniel, P.T.
Oncogene 21 (20): 3149-3161. 9 May 2002

bFGF signaling and v-Myb cooperate in sustained growth of primitive erythroid progenitors.
Bartunek, P. and Pajer, P. and Karafiat, V. and Blendinger, G. and Dvorak, M. and Zenke, M.
Oncogene 21 (3): 400-410. 17 January 2002

The apoptosis promoting Bcl-2 homologues Bak and Nbk/Bik overcome drug resistance in Mdr-1-negative and Mdr-1-overexpressing breast cancer cell lines.
Radetzki, S. and Koehne, C.H. and von Haefen, C. and Gillissen, B. and Sturm, I. and Doerken, B. and Daniel, P.T.
Oncogene 21 (2): 227-238. 10 January 2002

Sp1 as G1 cell cycle phase specific transcription factor in epithelial cells.
Grinstein, E. and Jundt, F. and Weinert, I. and Wernet, P. and Royer, H.D.
Oncogene 21 : 1485-1492. 1 January 2002

The breast proto-oncogene, HRGalpha regulates epithelial proliferation and lobuloalveolar development in the mouse mammary gland.
Li, L. and Cleary, S. and Mandarano, M.A. and Long, W.W. and Birchmeier, C. and Jones, F.E.
Oncogene 21 : 4900-4907. 1 January 2002

A rapid bioinformatic method identifies novel genes with direct clinical relevance to colon cancer.
Brett, D. and Kemmner, W. and Koch, G. and Roefzaad, C. and Gross, S. and Schlag, P.M.
Oncogene 20 (33): 4581-4585. 27 July 2001

Overexpression of caspase-3 restores sensitivity for drug-induced apoptosis in breast cancer cell lines with acquired drug resistance.
Friedrich, K. and Wieder, T. and von Haefen, C. and Radetzki, S. and Jaenicke, R. and Schulze-Osthoff, K. and Doerken, B. and Daniel, P.T.
Oncogene 20 (22): 2749-2760. 17 May 2001

The C-terminal SH3 domain of the adapter protein Grb2 binds with high affinity to sequences in Gab1 and SLP-76 which lack the SH3-typical P-x-x-P core motif.
Lewitzky, M. and Kardinal, C. and Gehring, N.H. and Schmidt, E.K. and Konkol, B. and Eulitz, M. and Birchmeier, W. and Schaeper, U. and Feller, S.M.
Oncogene 20 (9): 1052-1062. 1 January 2001

Tumorigenic N-terminal deletions of c-Myb modulate DNA binding, transactivation, and cooperativity with C/EBP.
Oelgeschlager, M. and Kowenz-Leutz, E. and Schreek, S. and Leutz, A. and Luescher, B.
Oncogene 20 (50): 7420-7424. 1 January 2001

Mammary gland specific hEGF receptor transgene expression induces neoplasia and inhibits differentiation.
Brandt, R. and Eisenbrandt, R. and Leenders, F. and Zschiesche, W. and Binas, B. and Juergensen, C. and Theuring, F.
Oncogene 19 : 2129-2137. 20 April 2000

Cytokine response gene 6 induces p21 and regulates both cell growth and arrest.
Fan, W. and Richter, G. and Cereseto, A. and Beadling, C. and Smith, K.A.
Oncogene 18 : 6573-6582. 11 November 1999

The fibroblast growth factor receptor FGFR-4 acts as a ligand dependent modulator of erythroid cell proliferation.
Koritschoner, N.P. and Bartunek, P. and Knespel, S. and Blendinger, G. and Zenke, M.
Oncogene 18 (43): 5904-5914. 21 October 1999

Tumour-associated E-cadherin mutations alter cellular morphology, decrease cellular adhesion and increase cellular motility.
Handschuh, G. and Candidus, S. and Luber, B. and Reich, U. and Schott, C. and Oswald, S. and Becke, H. and Hutzler, P. and Birchmeier, W. and Hoefler, H. and Becker, K.F.
Oncogene 18 : 4301-4312. 29 July 1999

The Bcl-3 oncoprotein acts as a bridging factor between NF-kappa B/Rel and nuclear co-regulators.
Dechend, R. and Hirano, F. and Lehmann, K. and Heissmeyer, V. and Ansieau, S. and Wulczyn, F.G. and Scheidereit, C. and Leutz, A.
Oncogene 18 : 3316-3323. 3 June 1999

Molecular mechanisms of constitutive NF-kappaB/Rel activation in Hodgkin/Reed-Sternberg cells.
Krappmann, D. and Emmerich, F. and Kordes, U. and Scharschmidt, E. and Doerken, B. and Scheidereit, C.
Oncogene 18 : 943-953. 28 January 1999

Secretory Type II Phospholipase A2 (PLA2G2A) expression status in colorectal carcinoma derived cell lines and in normal colonic mucosa.
Praml, C. and Amler, L.C. and Dihlmann, S. and Finke, L.H. and Schlag, P.M. and Schwab, M.
Oncogene 17 : 2009-2012. 15 October 1998

Cyclin D3: requirement for G1/S transition and high abundance in quiescent tissues suggest a dual role in proliferation and differentiation.
Bartkova, J. and Lukas, J. and Strauss, M. and Bartek, J.
Oncogene 17 (8): 1027-1037. 27 August 1998

The Myb leucine zipper is essential for leukemogenicity of the v-Myb protein.
Bartunek, P. and Karafiat, V. and Dvorakova, M. and Zahorova, V. and Mandikova, S. and Zenke, M. and Dvorak, M.
Oncogene 15 (24): 2939-2949. 11 December 1997

Regulation of the urokinase-type plasminogen activator gene by the oncogene Tpr-Met involves GRB2.
Besser, D. and Bardelli, A. and Didichenko, S. and Thelen, M. and Comoglio, P.M. and Ponzetto, C. and Nagamine, Y.
Oncogene 14 (6): 705-711. 13 February 1997

Strong indication for a breast cancer susceptibility gene on chromosome 8p12-p22: linkage analysis in german breast cancer families.
Seitz, S. and Rohde, K. and Bender, E. and Nothnagel, A. and Koelble, K. and Schlag, P.M. and Scherneck, S.
Oncogene 14 (6): 741-743. 13 February 1997

Functional interference between retinoic acid or steroid hormone receptors and the oncoprotein Fli-1.
Darby, T.G. and Meissner, J. and Ruehlmann, A. and Mueller, W.H. and Scheibe, R.J.
Oncogene 15 : 3067-3082. 1 January 1997

A defined chromosome 6q fragment (at D6S310) harbors a putative tumor suppressor gene for breast cancer.
Theile, M. and Seitz, S. and Arnold, W. and Jandrig, B. and Frege, R. and Schlag, P.M. and Haensch, W. and Guski, H. and Winzer, K.J. and Barrett, J.C. and Scherneck, S.
Oncogene 13 (4): 677-685. 15 August 1996

The retinoblastoma protein modulates expression of genes coding for diverse classes of proteins including components of the extracellular matrix.
Rohde, M. and Warthoe, P. and Gjetting, T. and Lukas, J. and Bartek, J. and Strauss, M.
Oncogene 12 (11): 2393-2401. 6 June 1996

The BTB/POZ domain targets the LAZ3/BCL6 oncoprotein to nuclear dots and mediates homomerisation in vivo.
Dhordain, P. and Albagli, O. and Ansieau, S. and Koken, M. and Deweindt, C. and Quief, S. and Lantoine, D. and Leutz, A. and Kerckaert, J.P. and Leprince, D.
Oncogene 11 (12): 2689-2697. 21 December 1995

Urokinase-type plasminogen activator gene regulation by polyomavirus middle-T antigen.
Besser, D. and Urich, M. and Sakaue, M. and Messerschmitt, A. and Ballmer-Hofer, K. and Nagamine, Y.
Oncogene 11 (11): 2383-2391. 7 December 1995

Deletion mapping defines different regions in 1p34.2-pter that may harbor genetic information related to human colorectal cancer.
Praml, C. and Finke, L.H. and Herfarth, C. and Schlag, P.M. and Schwab, M. and Amler, L.
Oncogene 11 (7): 1357-1362. 5 October 1995

Suppression of tumorigenicity of breast cancer cells by transfer of human chromosome 17 does not require transferred BRCA1 and p53 genes.
Theile, M. and Hartmann, S. and Scherthan, H. and Arnold, W. and Deppert, W. and Frege, R. and Glaab, F. and Haensch, W. and Scherneck, S.
Oncogene 10 (3): 439-447. 2 February 1995

Immediate effects of reversible HTLV-I tax function: T-cell activation and apoptosis.
Chlichlia, K. and Moldenhauer, G. and Daniel, P.T. and Busslinger, M. and Gazzalo, L. and Schirrmacher, V. and Khazaie, K.
Oncogene 10 (2): 269-277. 19 January 1995

Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo.
Hennig, G. and Behrens, J. and Truss, M. and Frisch, S. and Reichmann, E. and Birchmeier, W.
Oncogene 11 : 475-484. 1 January 1995

Biochemical and functional characterization of the murine ros protooncogene.
Riethmacher, D. and Langholz, O. and Goedecke, S. and Sachs, M. and Birchmeier, C.
Oncogene 9 (12): 3617-3626. December 1994

Transcriptional repression and activation in the same cell type of the human c-MYC promoter by the retinoblastoma gene protein: antagonisation of both effects by SV40 T antigen.
Batsche, E. and Lipp, M. and Cremisi, C.
Oncogene 9 (8): 2235-2243. August 1994

BCL-1/cyclin D1 oncoprotein oscillates and subverts the G1 phase control in B-cell neoplasms carrying the t(11;14) translocation.
Lukas, J. and Jadayel, D. and Bartkova, J. and Nacheva, E. and Dyer, M.J.S. and Strauss, M. and Bartek, J.
Oncogene 9 (8): 2159-2167. August 1994

E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions.
Oswald, F. and Lovec, H. and Moeroey, T. and Lipp, M.
Oncogene 9 (7): 2029-2036. July 1994

Functional aspects of B-Myb in early Xenopus development.
Bouwmeester, T. and van Wijk, I. and Wedlich, D. and Pieler, T.
Oncogene 9 (4): 1029-1038. April 1994

NF-kappaB precursor p100 inhibits nuclear translocation and DNA binding of NF-kappaB/rel-factors.
Naumann, M. and Nieters, A. and Hatada, E.N. and Scheidereit, C.
Oncogene 8 (8): 2275-2281. 1 August 1993

Mutations within the hamster polyomavirus large T antigen domain involved in pRb binding impair virus productive cycle and immortalization capacity.
Goutebroze, L. and De La Roche Saint Andre, C. and Scherneck, S. and Feunteun, J.
Oncogene 8 : 685-693. 1 January 1993

Characterization of the transcriptional regulatory region of the human WT1 gene.
Hofmann, W. and Royer, H.D. and Drechsler, M. and Schneider, S. and Royer-Pokora, B.
Oncogene 8 : 3123-3132. 1 January 1993

Transcriptional activation and transformation by chimaeric Fos-estrogen receptor proteins: altered properties as a consequence of gene fusion.
Schuermann, M. and Hennig, G. and Mueller, R.
Oncogene 8 : 2781-2790. 1 January 1993

Modulation of normal erythroid differentiation by the endogenous thyroid hormone and retinoic acid receptors: a possible target for v-erbA oncogene action.
Schroeder, C. and Gibson, L. and Zenke, M. and Beug, H.
Oncogene 7 (2): 217-227. 1 February 1992

Stimulation of cell division and fibroblast focus formation by antisense repression of retinoblastoma protein synthesis.
Strauss, M. and Hering, S. and Lieber, A. and Herrmann, G. and Griffin, B.E. and Arnold, W.
Oncogene 7 : 769-773. 1 January 1992

Cell transformation by Int-2 - a member of the fibroblast growth factor family.
Goldfarb, M. and Deed, R. and MacAllan, D. and Walther, W. and Dickson, C. and Peters, G.
Oncogene 6 : 65-71. 1 January 1991

Review

The growing complexity of HIF-1α's role in tumorigenesis: DNA repair and beyond.
Rohwer, N. and Zasada, C. and Kempa, S. and Cramer, T.
Oncogene 32 (31): 3569-3576. 1 August 2013

IkappaB kinase complexes: gateways to NF-kappaB activation and transcription.
Scheidereit, C.
Oncogene 25 (51): 6685-6705. 30 October 2006

Role of morphogenetic factors in metastasis of mammary carcinoma cells.
Meiners, S. and Brinkmann, V. and Naundorf, H. and Birchmeier, W.
Oncogene 16 : 9-20. 1 January 1998